首页 > 最新文献

FP essentials最新文献

英文 中文
Male Sexual Disorders: Sexually Transmitted Infections. 男性性功能障碍:性传播感染。
Q3 Medicine Pub Date : 2025-05-01
Roland Newman, Benjamin Silverberg, Michael Partin, Roderick Clark

Sexually transmitted infections (STIs) in men can be caused by bacteria, viruses, or parasites. Patients present primarily with urethritis or skin manifestations. The most common STIs affecting men include gonorrhea; chlamydia; Mycoplasma and Ureaplasma infections; trichomoniasis; syphilis; chancroid; mpox (monkeypox); and infections with human papillomavirus; herpes simplex virus; hepatitis A, B, and C viruses; and HIV. Primary and secondary prevention strategies include vaccination, preexposure prophylaxis, condom use, and routine screening to reduce transmission and improve clinical outcomes. A thorough sexual history should be obtained from patients using the Centers for Disease Control and Prevention's 5Ps framework (ie, partners, practices, protection from STIs, past history of STIs, pregnancy intention). The National Coalition for Sexual Health has suggested a sixth P-plus-that represents pleasure, problems, and pride. The latest recommendations for prevention measures include doxycycline postexposure prophylaxis (doxy PEP) for certain high-risk groups.

男性的性传播感染(STIs)可以由细菌、病毒或寄生虫引起。患者主要表现为尿道炎或皮肤表现。影响男性的最常见性传播感染包括淋病;衣原体;支原体和脲原体感染;滴虫病;梅毒;软性下疳;mpox(猴痘);人类乳头瘤病毒感染;单纯疱疹病毒;甲型、乙型和丙型肝炎病毒;和艾滋病毒。一级和二级预防战略包括疫苗接种、暴露前预防、使用避孕套和常规筛查,以减少传播和改善临床结果。应该使用疾病控制和预防中心的5Ps框架(即,伴侣,行为,对性传播感染的保护,性传播感染的既往史,怀孕意图)从患者那里获得全面的性史。全国性健康联盟提出了第六个p +——代表快乐、问题和骄傲。最新的预防措施建议包括对某些高危人群使用强力霉素暴露后预防(doxy PEP)。
{"title":"Male Sexual Disorders: Sexually Transmitted Infections.","authors":"Roland Newman, Benjamin Silverberg, Michael Partin, Roderick Clark","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Sexually transmitted infections (STIs) in men can be caused by bacteria, viruses, or parasites. Patients present primarily with urethritis or skin manifestations. The most common STIs affecting men include gonorrhea; chlamydia; Mycoplasma and Ureaplasma infections; trichomoniasis; syphilis; chancroid; mpox (monkeypox); and infections with human papillomavirus; herpes simplex virus; hepatitis A, B, and C viruses; and HIV. Primary and secondary prevention strategies include vaccination, preexposure prophylaxis, condom use, and routine screening to reduce transmission and improve clinical outcomes. A thorough sexual history should be obtained from patients using the Centers for Disease Control and Prevention's 5Ps framework (ie, partners, practices, protection from STIs, past history of STIs, pregnancy intention). The National Coalition for Sexual Health has suggested a sixth P-plus-that represents pleasure, problems, and pride. The latest recommendations for prevention measures include doxycycline postexposure prophylaxis (doxy PEP) for certain high-risk groups.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"552 ","pages":"29-38"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Male Sexual Disorders: Infertility and Low Libido. 男性性功能障碍:不育和性欲低下。
Q3 Medicine Pub Date : 2025-05-01
Roderick Clark, Roland Newman, Benjamin Silverberg, Michael Partin

Infertility is defined as failure to achieve pregnancy after 12 months or more of regular, unprotected intercourse. Infertility is presumed after 12 months when the female partner is younger than 35 years, and after 6 months when the female partner is older than 35 years. Couples attempting to conceive should be encouraged to engage in intercourse every 1 to 2 days and can track ovulation to maximize the likelihood of conception. Evaluation of male infertility should include assessment for underlying medical conditions that may affect fertility and at least one semen analysis. Approximately 25% of couples have unexplained infertility. Assisted reproductive technology can be used to achieve pregnancy, including for couples who do not have an identified cause of infertility. Low libido in men is a poorly understood phenomenon that is underdiagnosed in clinical practice. The degree of distress associated with lack of sexual desire is essential to the diagnosis. The Sexual Desire Inventory-2 can be used to initiate discussion with patients and assess libido. Clinicians should rule out factors that can contribute to low libido (eg, endocrinopathies, testosterone deficiency, mental health conditions, relationship issues) and support patients in achieving their goals regarding sexual health. Testosterone replacement therapy should be considered for men with low libido and testosterone deficiency.

不孕症的定义是在12个月或更长时间的定期无保护性交后仍未怀孕。如果女性伴侣年龄小于35岁,则在12个月后推定不孕;如果女性伴侣年龄大于35岁,则在6个月后推定不孕。应鼓励试图怀孕的夫妇每1至2天进行一次性交,并跟踪排卵以最大限度地提高受孕的可能性。男性不育症的评估应包括对可能影响生育能力的潜在医疗条件的评估和至少一项精液分析。大约25%的夫妇有不明原因的不孕症。辅助生殖技术可用于实现怀孕,包括那些没有确定不孕原因的夫妇。男性性欲低下是一个鲜为人知的现象,在临床实践中诊断不足。与性欲缺乏相关的痛苦程度是诊断的关键。性欲量表-2可用于与患者展开讨论并评估性欲。临床医生应该排除可能导致性欲低下的因素(例如,内分泌疾病、睾酮缺乏、精神健康状况、关系问题),并支持患者实现他们的性健康目标。对于性欲低下和睾酮缺乏的男性应考虑睾酮替代疗法。
{"title":"Male Sexual Disorders: Infertility and Low Libido.","authors":"Roderick Clark, Roland Newman, Benjamin Silverberg, Michael Partin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Infertility is defined as failure to achieve pregnancy after 12 months or more of regular, unprotected intercourse. Infertility is presumed after 12 months when the female partner is younger than 35 years, and after 6 months when the female partner is older than 35 years. Couples attempting to conceive should be encouraged to engage in intercourse every 1 to 2 days and can track ovulation to maximize the likelihood of conception. Evaluation of male infertility should include assessment for underlying medical conditions that may affect fertility and at least one semen analysis. Approximately 25% of couples have unexplained infertility. Assisted reproductive technology can be used to achieve pregnancy, including for couples who do not have an identified cause of infertility. Low libido in men is a poorly understood phenomenon that is underdiagnosed in clinical practice. The degree of distress associated with lack of sexual desire is essential to the diagnosis. The Sexual Desire Inventory-2 can be used to initiate discussion with patients and assess libido. Clinicians should rule out factors that can contribute to low libido (eg, endocrinopathies, testosterone deficiency, mental health conditions, relationship issues) and support patients in achieving their goals regarding sexual health. Testosterone replacement therapy should be considered for men with low libido and testosterone deficiency.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"552 ","pages":"7-12"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Male Sexual Disorders: Penile Disorders. 男性性功能障碍:阴茎障碍。
Q3 Medicine Pub Date : 2025-05-01
Benjamin Silverberg, Michael Partin, Roderick Clark, Roland Newman

Erectile dysfunction can result from organic, psychogenic, or substance-induced causes. Phosphodiesterase type 5 inhibitors are the mainstay of medical treatment, although other medications and interventions, such as intracavernosal injection therapy and constriction devices, can also be used. Priapism is defined as a prolonged erection of the penis continuing after or irrespective of sexual stimulation. It may result from conditions causing ischemic states or dysregulation of arterial inflow. Acute ischemic priapism is a medical emergency and can result in irreversible erectile dysfunction. Nonischemic priapism is not an emergent condition and should resolve spontaneously. Phimosis, or inability to fully retract the penile prepuce over the glans, is a congenital or acquired condition and can cause discomfort. Physiologic phimosis usually resolves by age 16 years, whereas pathologic phimosis may require circumcision for definitive treatment. Paraphimosis, an emergent condition, results from the foreskin becoming trapped proximal to the coronal sulcus. Treatment consists of manual reduction. In Peyronie disease, fibrous plaques develop in the penile shaft, subsequently causing deformity of the penis when erect. Surgical and nonsurgical treatment options, such as collagenase or intralesional injections, are available.

勃起功能障碍可由器质性、精神性或物质诱发的原因引起。磷酸二酯酶5型抑制剂是医学治疗的主要手段,但也可以使用其他药物和干预措施,如海绵体内注射治疗和收缩装置。阴茎勃起被定义为阴茎在性刺激后或不受性刺激而持续的长时间勃起。它可能由引起缺血状态或动脉流入失调的条件引起。急性缺血性勃起功能障碍是一种医学急症,可导致不可逆的勃起功能障碍。非缺血性阴茎勃起不是一种紧急情况,应该自发消退。包茎,或无法完全收回阴茎包皮的龟头,是一种先天性或后天的条件,可引起不适。生理性包茎通常在16岁时消退,而病理性包茎可能需要包皮环切术进行最终治疗。包皮病是一种紧急情况,是由于包皮被困在冠状沟的近端而引起的。治疗包括手动复位。在佩罗尼病中,纤维斑块在阴茎轴上形成,随后引起阴茎勃起时的畸形。手术和非手术治疗的选择,如胶原酶或局部注射,是可用的。
{"title":"Male Sexual Disorders: Penile Disorders.","authors":"Benjamin Silverberg, Michael Partin, Roderick Clark, Roland Newman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Erectile dysfunction can result from organic, psychogenic, or substance-induced causes. Phosphodiesterase type 5 inhibitors are the mainstay of medical treatment, although other medications and interventions, such as intracavernosal injection therapy and constriction devices, can also be used. Priapism is defined as a prolonged erection of the penis continuing after or irrespective of sexual stimulation. It may result from conditions causing ischemic states or dysregulation of arterial inflow. Acute ischemic priapism is a medical emergency and can result in irreversible erectile dysfunction. Nonischemic priapism is not an emergent condition and should resolve spontaneously. Phimosis, or inability to fully retract the penile prepuce over the glans, is a congenital or acquired condition and can cause discomfort. Physiologic phimosis usually resolves by age 16 years, whereas pathologic phimosis may require circumcision for definitive treatment. Paraphimosis, an emergent condition, results from the foreskin becoming trapped proximal to the coronal sulcus. Treatment consists of manual reduction. In Peyronie disease, fibrous plaques develop in the penile shaft, subsequently causing deformity of the penis when erect. Surgical and nonsurgical treatment options, such as collagenase or intralesional injections, are available.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"552 ","pages":"13-20"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Male Sexual Disorders: Ejaculatory Disorders. 男性性功能障碍:射精障碍。
Q3 Medicine Pub Date : 2025-05-01
Michael Partin, Roderick Clark, Roland Newman, Benjamin Silverberg

Disorders of ejaculation include premature ejaculation, delayed ejaculation, retrograde ejaculation, and hematospermia. Lifelong premature ejaculation is defined as ejaculation always or nearly always within 1 minute of vaginal penetration that has been present since the first sexual encounter. Acquired premature ejaculation typically begins after a period of normal function, with ejaculation occurring within 3 minutes of penetration. Treatment options include medications and behavioral techniques. Selective serotonin reuptake inhibitors and tricyclic antidepressants are first-line drugs. Delayed ejaculation applies to a range of issues, from delay to complete absence of ejaculation. Guidelines suggest use of an ejaculatory latency time greater than 25 to 30 minutes for diagnosis. Etiologies include psychological and organic factors, such as adverse effects of medications. Treatment focuses on causal medication discontinuation, psychological interventions, and use of off-label drug therapy. Retrograde ejaculation occurs when semen enters the bladder due to an anatomic, neurogenic, or pharmacologic cause. Treatment options include sympathomimetic medications and surgical correction of anatomic abnormalities. Hematospermia, or blood in the semen, is generally benign and self-limited. However, underlying malignancy is possible and should be considered based on patient age and risk factors. Treatment ranges from reassurance to management of the underlying cause.

射精障碍包括早泄、延迟射精、逆行射精和血精。终身早泄被定义为总是或几乎总是在第一次性接触后阴道插入1分钟内射精。获得性早泄通常在一段时间的正常功能后开始,射精发生在3分钟内插入。治疗方案包括药物治疗和行为技术。选择性血清素再摄取抑制剂和三环类抗抑郁药是一线药物。延迟射精适用于一系列问题,从延迟到完全没有射精。指南建议使用射精潜伏期大于25 - 30分钟的诊断。病因包括心理和器质性因素,如药物的不良反应。治疗的重点是因果药物停药,心理干预和使用标签外药物治疗。当精液由于解剖学、神经源性或药理学原因进入膀胱时,发生逆行射精。治疗方案包括拟交感神经药物和解剖异常的手术矫正。血精症,或精液中有血,通常是良性且自限性的。然而,潜在的恶性肿瘤是可能的,应该根据患者的年龄和危险因素来考虑。治疗范围从安抚到控制根本原因。
{"title":"Male Sexual Disorders: Ejaculatory Disorders.","authors":"Michael Partin, Roderick Clark, Roland Newman, Benjamin Silverberg","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Disorders of ejaculation include premature ejaculation, delayed ejaculation, retrograde ejaculation, and hematospermia. Lifelong premature ejaculation is defined as ejaculation always or nearly always within 1 minute of vaginal penetration that has been present since the first sexual encounter. Acquired premature ejaculation typically begins after a period of normal function, with ejaculation occurring within 3 minutes of penetration. Treatment options include medications and behavioral techniques. Selective serotonin reuptake inhibitors and tricyclic antidepressants are first-line drugs. Delayed ejaculation applies to a range of issues, from delay to complete absence of ejaculation. Guidelines suggest use of an ejaculatory latency time greater than 25 to 30 minutes for diagnosis. Etiologies include psychological and organic factors, such as adverse effects of medications. Treatment focuses on causal medication discontinuation, psychological interventions, and use of off-label drug therapy. Retrograde ejaculation occurs when semen enters the bladder due to an anatomic, neurogenic, or pharmacologic cause. Treatment options include sympathomimetic medications and surgical correction of anatomic abnormalities. Hematospermia, or blood in the semen, is generally benign and self-limited. However, underlying malignancy is possible and should be considered based on patient age and risk factors. Treatment ranges from reassurance to management of the underlying cause.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"552 ","pages":"21-28"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Male Sexual Disorders: Foreword. 男性性功能障碍:前言。
Q3 Medicine Pub Date : 2025-05-01
Kate Rowland
{"title":"Male Sexual Disorders: Foreword.","authors":"Kate Rowland","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"552 ","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Thinking Upstream: Social and Structural Determinants of Health. 将健康的社会和结构决定因素纳入临床实践:上游思考:健康的社会和结构决定因素。
Q3 Medicine Pub Date : 2025-04-01
Jason E Glenn

The health impact of the conditions in which people are born, grow, work, live, and age have been recognized for centuries. However, widespread acceptance of this impact remains contentious, as inequities in morbidity and mortality represent the enduring legacies of displacement, oppression, and systemic discrimination. The World Health Organization estimates that social and structural determinants are responsible for 30% to 55% of all health outcomes. Social determinants of health, structural determinants of health, structural violence, and the need for structural competency are four codependent concepts that must be explored together to develop responsive clinical interventions. Social and structural determinants of health include wealth and social status, geography and neighborhood, employment and labor, and education. Racism is a major driver of social and structural determinants of health in the United States. It is important to differentiate between upstream and downstream approaches to addressing health inequities because addressing upstream factors has a greater impact.

人们出生、成长、工作、生活和衰老的条件对健康的影响已被认识了几个世纪。然而,对这种影响的广泛接受仍然存在争议,因为发病率和死亡率的不平等代表着流离失所、压迫和系统性歧视的持久遗产。世界卫生组织估计,社会和结构决定因素对所有健康结果的30%至55%负有责任。健康的社会决定因素、健康的结构性决定因素、结构性暴力和对结构性能力的需求是四个相互依存的概念,必须共同探索,以制定响应性临床干预措施。健康的社会和结构决定因素包括财富和社会地位、地理和邻里关系、就业和劳动以及教育。种族主义是美国健康的社会和结构决定因素的主要驱动因素。重要的是要区分解决卫生不平等问题的上游和下游方法,因为解决上游因素的影响更大。
{"title":"Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Thinking Upstream: Social and Structural Determinants of Health.","authors":"Jason E Glenn","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The health impact of the conditions in which people are born, grow, work, live, and age have been recognized for centuries. However, widespread acceptance of this impact remains contentious, as inequities in morbidity and mortality represent the enduring legacies of displacement, oppression, and systemic discrimination. The World Health Organization estimates that social and structural determinants are responsible for 30% to 55% of all health outcomes. Social determinants of health, structural determinants of health, structural violence, and the need for structural competency are four codependent concepts that must be explored together to develop responsive clinical interventions. Social and structural determinants of health include wealth and social status, geography and neighborhood, employment and labor, and education. Racism is a major driver of social and structural determinants of health in the United States. It is important to differentiate between upstream and downstream approaches to addressing health inequities because addressing upstream factors has a greater impact.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"550 ","pages":"11-16"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144020099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Creating a Welcoming Practice and Building Diversity Among the Health Care Team. 将健康的社会和结构决定因素纳入临床实践:在卫生保健团队中创造一个受欢迎的实践和建立多样性。
Q3 Medicine Pub Date : 2025-04-01
Marial Alonso-Luaces

Despite extensive research documenting the potential of diversity, health equity, and inclusion initiatives to improve outcomes for the most vulnerable patients, attacks on these efforts in both private and public sector health care institutions are proliferating. Given demographic trends in the United States, diverse health care teams are a strategic necessity to bolster the experiences and outcomes of marginalized patients, foster inclusive research and innovation, and lower health care expenditures. To create diverse health care teams, physicians and allies must deepen their understanding of the complexities of structural racism and address the socially imposed forces that persist and result in the loss of underrepresented minorities on the path to health careers. Practicing physicians and other health care professionals can individually and collectively contribute to the development, recruitment, and retention of a more diverse and inclusive workforce to serve all patients. Strategies that physicians can use to achieve this goal include making diversity core to the practice's mission, focusing on retention, connecting with local school districts and colleges, and striving for more equitable policies and procedures.

尽管广泛的研究记录了多样性、卫生公平和包容性举措在改善最弱势患者预后方面的潜力,但私营和公共部门卫生保健机构对这些努力的攻击正在激增。考虑到美国的人口趋势,多样化的医疗团队是一种战略需要,以加强边缘化患者的经验和结果,促进包容性研究和创新,并降低医疗支出。为了创建多样化的医疗保健团队,医生和盟友必须加深对结构性种族主义复杂性的理解,并解决社会强加的力量,这些力量持续存在,导致代表性不足的少数群体在通往卫生事业的道路上丧失。执业医师和其他卫生保健专业人员可以单独或集体地为发展、招聘和留住一支更加多样化和包容性的劳动力队伍做出贡献,为所有患者服务。医生可以采用的实现这一目标的策略包括将多元化作为实践使命的核心,关注保留,与当地学区和学院联系,争取更公平的政策和程序。
{"title":"Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Creating a Welcoming Practice and Building Diversity Among the Health Care Team.","authors":"Marial Alonso-Luaces","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Despite extensive research documenting the potential of diversity, health equity, and inclusion initiatives to improve outcomes for the most vulnerable patients, attacks on these efforts in both private and public sector health care institutions are proliferating. Given demographic trends in the United States, diverse health care teams are a strategic necessity to bolster the experiences and outcomes of marginalized patients, foster inclusive research and innovation, and lower health care expenditures. To create diverse health care teams, physicians and allies must deepen their understanding of the complexities of structural racism and address the socially imposed forces that persist and result in the loss of underrepresented minorities on the path to health careers. Practicing physicians and other health care professionals can individually and collectively contribute to the development, recruitment, and retention of a more diverse and inclusive workforce to serve all patients. Strategies that physicians can use to achieve this goal include making diversity core to the practice's mission, focusing on retention, connecting with local school districts and colleges, and striving for more equitable policies and procedures.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"550 ","pages":"17-23"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Addressing Health Equity in Your Practice and Community. 将健康的社会和结构决定因素纳入临床实践:在你的实践和社区解决健康公平。
Q3 Medicine Pub Date : 2025-04-01
Erin Corriveau

Seeking heath equity means striving to give everyone a fair opportunity to be as healthy as possible by working to eliminate health disparities and determinants that adversely affect certain groups. An alternative framework is to define health equity by quality of outcomes. Numerous family medicine organizations have argued that health equity is central to the practice of medicine, adding convenience, cultural humility, structural competency, community engagement, and collaboration to the core tenets of primary care. Many family medicine educators have embraced a focus on health equity within practices as foundational to training future physicians. Aspects of the health care system that perpetuate inequity include fee-for-service payment models (which create untenable expenses for patients and pressure on clinicians to increase volume) and capitation models (which can lead to the underprovision of care for patients). Practicing care that is trauma- and violence-informed, culturally safe, and contextually tailored predicts better outcomes for patients and can help reduce moral injury for the clinician. Family physicians are uniquely positioned to work with patients, communities, and partners to create a more equitable health care system.

寻求健康公平意味着通过努力消除对某些群体产生不利影响的健康差距和决定因素,努力为每个人提供尽可能健康的公平机会。另一种框架是根据结果的质量来定义卫生公平。许多家庭医学组织认为,健康公平是医疗实践的核心,为初级保健的核心原则增加了便利、文化谦逊、结构能力、社区参与和合作。许多家庭医学教育工作者都将注重实践中的健康公平作为培训未来医生的基础。卫生保健系统中使不平等现象永久化的方面包括按服务收费的支付模式(这给患者造成了难以承受的费用,并给临床医生带来了增加业务量的压力)和按人头收费的模式(这可能导致对患者提供的护理不足)。实践了解创伤和暴力、文化安全、根据具体情况量身定制的护理可以为患者带来更好的结果,并有助于减少临床医生的道德伤害。家庭医生在与患者、社区和合作伙伴一起创造更加公平的卫生保健系统方面具有独特的地位。
{"title":"Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Addressing Health Equity in Your Practice and Community.","authors":"Erin Corriveau","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Seeking heath equity means striving to give everyone a fair opportunity to be as healthy as possible by working to eliminate health disparities and determinants that adversely affect certain groups. An alternative framework is to define health equity by quality of outcomes. Numerous family medicine organizations have argued that health equity is central to the practice of medicine, adding convenience, cultural humility, structural competency, community engagement, and collaboration to the core tenets of primary care. Many family medicine educators have embraced a focus on health equity within practices as foundational to training future physicians. Aspects of the health care system that perpetuate inequity include fee-for-service payment models (which create untenable expenses for patients and pressure on clinicians to increase volume) and capitation models (which can lead to the underprovision of care for patients). Practicing care that is trauma- and violence-informed, culturally safe, and contextually tailored predicts better outcomes for patients and can help reduce moral injury for the clinician. Family physicians are uniquely positioned to work with patients, communities, and partners to create a more equitable health care system.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"550 ","pages":"24-29"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Foreword. 将健康的社会和结构决定因素纳入临床实践:前言。
Q3 Medicine Pub Date : 2025-04-01
Ryan D Kauffman
{"title":"Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Foreword.","authors":"Ryan D Kauffman","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"550 ","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Risks of Race-Based Medicine. 将健康的社会和结构决定因素纳入临床实践:基于种族的医学风险。
Q3 Medicine Pub Date : 2025-04-01
Carla Keirns

Modern medicine has developed over the past 2 centuries in societies stratified by race and ethnicity. Race-based medicine analyzes health risks and treatment based on a patient's race, often assuming that differences in health status are due to biology and genetics. In the United States, there is a history of guidelines using race-based decision-making for a variety of conditions (eg, hypertension, heart failure). These guidelines lead to profound health disparities. Genetic tests reveal precise molecular causes for differences in therapeutic and adverse effects of medications, and certain genetic variants are more common in specific groups of people. At the same time, there is growing evidence on health disparities that shows stratification of social determinants of health by race, ethnicity, income, and geography. Race-based prescribing guidelines and race-correction factors are under review across medicine to ensure that accurate data are used to provide unbiased care and that guidelines are not worsening health disparities. Race-conscious medicine focuses on the understanding that, although racial differences in health status may be influenced by genetics and epigenetics, they are just as likely to be due to racial stratification in access to resources, experiences of bias and discrimination, and social factors correlated with race.

现代医学在过去的两个世纪里是在按种族和民族划分的社会中发展起来的。基于种族的医学根据患者的种族分析健康风险和治疗,通常假设健康状况的差异是由于生物学和遗传学造成的。在美国,对各种疾病(如高血压、心力衰竭)采用基于种族的决策的指导方针已有历史。这些指导方针导致了严重的健康差距。基因测试揭示了药物治疗和副作用差异的精确分子原因,某些基因变异在特定人群中更为常见。与此同时,越来越多关于健康差异的证据表明,健康的社会决定因素按种族、民族、收入和地理存在分层。基于种族的处方指南和种族校正因素正在对整个医学进行审查,以确保使用准确的数据来提供公正的护理,并确保指南不会加剧健康差距。有种族意识的医学着重于这样一种认识,即尽管健康状况的种族差异可能受到遗传学和表观遗传学的影响,但它们同样可能是由于获得资源的种族分层、偏见和歧视的经历以及与种族相关的社会因素造成的。
{"title":"Incorporating the Social and Structural Determinants of Health Into Clinical Practice: Risks of Race-Based Medicine.","authors":"Carla Keirns","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Modern medicine has developed over the past 2 centuries in societies stratified by race and ethnicity. Race-based medicine analyzes health risks and treatment based on a patient's race, often assuming that differences in health status are due to biology and genetics. In the United States, there is a history of guidelines using race-based decision-making for a variety of conditions (eg, hypertension, heart failure). These guidelines lead to profound health disparities. Genetic tests reveal precise molecular causes for differences in therapeutic and adverse effects of medications, and certain genetic variants are more common in specific groups of people. At the same time, there is growing evidence on health disparities that shows stratification of social determinants of health by race, ethnicity, income, and geography. Race-based prescribing guidelines and race-correction factors are under review across medicine to ensure that accurate data are used to provide unbiased care and that guidelines are not worsening health disparities. Race-conscious medicine focuses on the understanding that, although racial differences in health status may be influenced by genetics and epigenetics, they are just as likely to be due to racial stratification in access to resources, experiences of bias and discrimination, and social factors correlated with race.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"550 ","pages":"6-10"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
FP essentials
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1